Untitled

HealthTrust presents...”Updates on Heart Failure with Reduced Ejection Fraction (HFrEF): A Focus on Emerging Therapies”

Download the content

Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.

Since the publication of the 2017 ECDP for Optimization of Heart Failure Treatment, new therapies have emerged that expand the armamentarium for the treatment of patients with HFrEF. HFrEF is a complex syndrome managed with multiple classes of medications. The purpose of this presentation is to review the medication-related updates from the 2021 Focused Update to the 2017 Expert Consensus Decision Pathway (ECDP) for Optimization of Heart Failure Treatment. In addition, the presentation will introduce vericiguat and omecamtiv mecarbil and discuss their potential role as emerging therapies in heart failure.

Learning Objectives for Pharmacists & Nurses  |  At the end of this session, participants should be able to:

1. Recall rationale behind therapeutic updates addressed in the 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment
2. Recognize the proposed mechanisms of action and adverse effects of vericiguat and omecamtiv mecarbil and their potential role in heart failure
3. Identify clinical evidence supporting the use of vericiguat and omecamtiv mecarbil in heart failure

Learning Objectives for Pharmacy Techs  |  At the end of this session, participants should be able to:

1. Recall barriers and cost considerations associated with novel treatments in heart failure
2. Recognize how emerging heart failure therapies are supplied and dosed
3. Identify safety considerations with vericiguat and omecamtiv mecarbil

Presenter:

Niti Shah, PharmD  |  PGY-1 Pharmacy Resident  |  Atlantic Health System (AHS)

Target Audience: Pharmacists, Pharmacy Techs & Nurses

Continuing Education Information: 1.0 contact hours approved for Pharmacists, Pharmacy Techs & Nurses. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-22-021-L01-P and 0863-9999-22-021-L01-T. The activity is approved for 1 hour of continuing education credit to pharmacists, pharmacy techs and nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.